The demand for advanced chips to power artificial intelligence is only growing, and one efficiency-focused company is preparing to make its initial public offering amid the boom. Ambiq Micro Inc.

Your weekly strategic brief on the cyber threat landscape. Uncover the deeper patterns behind attacks, from bootkit malware ...

Abstract: Large Language Models (LLMs) have transformed various fields with their remarkable ability to comprehend and generate human-like text. Despite these advancements, their effectiveness in ...

Federal Reserve Bank of Chicago President Austan Goolsbee said he’s still undecided on what course of action he will support at the central bank’s Sept. 16-17 meeting, pointing to inflation data due ...

Employers added only 22,000 jobs in August, and the unemployment rate rose slightly to 4.3 percent. Revised data also showed that employment fell by 13,000 jobs in June, the first net loss since ...

Letters have started arriving for people affected by the 2023 data breach at Premier Health that resulted in the possible exposure of Social Security numbers, medical information and other private ...

REC-R1 is a general framework that bridges generative large language models (LLMs) and recommendation systems via reinforcement learning. Check the paper here.

Google avoided harsh antitrust penalties for its conduct in the U.S. search market, with a judge barring the company from entering into exclusive deals but rejecting a forced spinoff of its Chrome ...

OpenAI to Build 1GW Data Centre in India Under Stargate Initiative Your email has been sent The new facility will be one of the largest in the country. OpenAI's CEO Sam Altman. Image: Creative Commons ...

Abstract: Human Activity Recognition (HAR) stands as a crucial technology, with applications ranging from healthcare monitoring to sports analytics. However, the traditional approach to HAR is often ...

Welcome to CalMatters, the only nonprofit newsroom devoted solely to covering issues that affect all Californians. Sign up for WhatMatters to receive the latest news and commentary on the most ...

A panel convened in July 2025 by the Food and Drug Administration sparked controversy by casting doubt about the safety of commonly used antidepressants during pregnancy. But it also raised the ...